Skip to content

Role of Ayurvedic Protocol in Ensuring Smooth and Safe Normal Delivery: A Randomized Controlled Trial

A Randomized Controlled Trial To Evaluate The Efficacy Of Ayurvedic Protocol In Achieving Sukhaprasava - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102403
Enrollment
60
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

None listed

Sponsors

NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients in active stage of labor [Cervical dilatation 4cm or more than 4cm.] at full term with singleton pregnancy, cephalic presentation, Primigravida or multigravida and Adequate Pelvis. Patient between age of 21- 40 years. Hemoglobin more than or equal to 10gm/dl

Exclusion criteria

Exclusion criteria: Patients not in active stage of labor and not at full term pregnancy.. Foetal Presentation other than cephalic. Cervival dilatation less than 4cm. Patient having Bad obstetric history, precocious pregnancy History of previous LSCS( Lower Segment Caesarean Section) Pregnancy associated with severe Pregnancy induced hypertension, Pre-eclampsia, Eclampsia, Gestational Diabetes, Placenta previa, Abruptio placentae, severe oligohydramnios, severe polyhydramnios, severe IUGR(Intra Uterine Growth Restriction). Patients with Cephalo-pelvic disproportion. Patients suffering with systemic disorders like Diabetes Mellitus, Renal dysfunction, Cardiac disorder, Tuberculosis, Coagulopathies. Patients diagnosed with Benign or Malignant tumor of Reproductive system, Recto vaginal fistula, Vesico-vaginal fistula, second and third degree uterine prolapse History of Fothergill repair, Recto vaginal fistula, Vesico-vaginal fistula VDRL, HIV, HBsAg positive pregnant woman.

Design outcomes

Primary

MeasureTime frame
Achieving Sukhaprasava (Normal Vaginal Delivery) by spontaneous with rhythmic and painful uterine contractions, progressive effacement and dilatation of cervix and delivery of foetus and placenta with minimal aid at the end of the trial.Timepoint: Achieving Sukhaprasava (Normal Vaginal Delivery) by spontaneous with rhythmic and painful uterine contractions, progressive effacement and dilatation of cervix and delivery of foetus and placenta with minimal aid.

Secondary

MeasureTime frame
Difference in complications of third stages of labor which is Primary PPH. Difference in the rate of Sukhaprasava (Eutocia) & Shalyakruta Prasava (Caesarean section) between the groups Difference in the occurance of delayed labor & fetal distress between the groupsTimepoint: To assess the safety by 1. Maternal safety: absence of major labor-related complications. 2.Neonatal safety (favourable APGAR scores at 1 & 5 minutes)

Countries

India

Contacts

Public ContactDr Bharathi kumaramangalam

NATIONAL INSTITUTE OF AYURVEDA, JAIPUR RAJASTHAN

baruhunt@gmail.com9799997940

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026